Insulet Corporation Stock Earnings Reports
PODD Upcoming Earnings (Q3 2023)
Earnings Date: | Nov 01, 2023 |
Consensus EPS: | Premium |
Current P/E* ratio: 171.49 | Price (Sep 25, 2023, EOD): $154.67
*The P/E ratio (price-to-earnings ratio) is a financial metric used to assess a company's stock valuation. It is calculated by dividing the stock price by its earnings per share. A higher ratio suggests higher investor expectations, while a lower ratio may indicate undervaluation. It helps investors evaluate potential investments, but it's essential to consider other factors too.
Last 3 Quarters for PODD Premium
FAQ
About Insulet Corporation
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly i... PODD Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.